Mount Sinai Hospital
1 Gustave L. Levy Pl New York, NY 10029
Year Built: 1855
Number of Beds: 1,144 beds
Number of Physicians: 4
Mesothelioma Treatment in New York
Table Of Contents
New York has top mesothelioma treatments available to mesothelioma patients. Researchers in New York are searching for a mesothelioma cure by testing photodynamic therapy in patients. Cancer centers and hospitals across New York are participating in mesothelioma clinical trials.
Written by: Karen Selby, RN | Edited By Walter Pacheco | Last Update: March 12, 2025
"Most helpful, steered us in the right direction for treatmen...." see more
Elaine C. - Mesothelioma Patient
"Because of their guidance, I was able to navigate getting my...." see more
Deanna B. - Daughter of a Mesothelioma Patient
"Hearing the news about my mother's diagnosis was heartbreaki...." see more
Danielle W. - Daughter of a Mesothelioma Patient
"My son Carlos was diagnosed with this terrible and unknown d...." see more
Martha M. - Mother of a Mesothelioma Patient
"Extremely communicative and helped my dad get an appointment...." see more
Sunni H. - Loved One of a Mesothelioma Patient
"Danielle DiPietro was an invaluable resource for me. Her sug...." see more
Deborah C. - Spouse of a Mesothelioma Patient
"I was very grateful and appreciative of Dr. Smart from The M...." see more
Kimberlin C. - Spouse of a Mesothelioma Patient
"In January of 2016, my husband was diagnosed with peritoneal...." see more
Gloria R. - Spouse of a Mesothelioma Patient
Mesothelioma Treatment Centers in New York
Mesothelioma patients in New York visit Mount Sinai Hospital in Manhattan for its experts. They also benefit from its extensive history of research on asbestos-related diseases. In 2022, thoracic surgeon Dr. Andrea Wolf at Mount Sinai launched a mesothelioma vaccine clinical trial.
Patients also visit NYU Langone Medical Center. There, they can participate in innovative clinical trials and receive care from a team of mesothelioma doctors. Facilities include two hospitals and six clinical centers located throughout Manhattan.
Upstate residents visit Roswell Park Comprehensive Cancer Center in Buffalo for its surgeons. The surgeons here specialize in peritoneal and pleural mesothelioma. Patients looking for clinical trials will find a number of active studies at Roswell Park.
Top New York Mesothelioma Cancer Centers
Perlmutter Cancer Center
160 E. 34th St New York, NY 10016
Year Built: 1841
Number of Beds: 1,069 beds
Number of Physicians: 3
Roswell Park Comprehensive Cancer Center
120 Carlton St, Buffalo, NY 14203, USA
Year Built: 1898
Number of Beds: 157
Number of Physicians: 3
Maimonides Medical Center
4802 10th Ave, Brooklyn, New York 11219
Year Built: 1911
Number of Physicians: 2
Some New Yorkers may need financial assistance to pay for medical treatment. They should consider speaking with a New York mesothelioma lawyer to learn more about their legal options. Asbestos manufacturers in New York may be liable for your asbestos exposure disease.
Mesothelioma Specialists in New York
Patients in New York turn to Flores. He is a widely respected thoracic surgeon and longtime pleural mesothelioma specialist at Mount Sinai Hospital. He has conducted many mesothelioma studies. Flores is also an active patient advocate in the mesothelioma community.
Mesothelioma patients who don’t qualify for surgery see Dr. Daniel H. Sternman. He is a pleural mesothelioma expert. Sternman is also NYU Langone Medical Center’s Multidisciplinary Pulmonary Oncology Program director. He is an expert in gene therapy. Sternman is board-certified in internal medicine and pulmonary medicine.
Peritoneal mesothelioma patients in New York turn to Dr. John M. Kane III at Roswell Park Comprehensive Cancer Center. Roswell provides access to the most effective mesothelioma treatment. The procedure helps many who receive it live for at least five years.
Top New York Mesothelioma Doctors
New York, New York
Raja Michael Flores
Pleural Specialist | Thoracic Surgery
Expertise: Pleural Mesothelioma, Pleurectomy and Decortication Surgery, Lung Cancer, VATS, Lobectomy, Thoracotomy and Clinical Research
Languages: English, Spanish
New York, New York
Daniel H. Sterman
Pleural Specialist | Interventional Pulmonology
Expertise: Thoracic Diseases Minimally Invasive Procedures
Languages: English
Buffalo, New York
John M. Kane III
Peritoneal Specialist | Surgical Oncology
Expertise: Cytoreductive Surgery HIPEC
Languages: English
New York’s Advancements in Immunotherapy Research
New York ranks No. 5 in the nation for mesothelioma and asbestosis deaths. The state’s high ranking is attributed to its extensive industrial and commercial use of asbestos products in buildings and countless job sites.
Asbestos-related mortality is expected to increase in New York. This is because of the Sept. 11 attacks that released asbestos dust across lower Manhattan. It is a top concern for pleural mesothelioma specialist and thoracic surgeon Dr. Raja Flores at Mount Sinai Hospital.
Mesothelioma cancer centers and researchers in New York have made significant strides in immunotherapy research. For example, several locations throughout the state have contributed to advances in CAR T-cell therapy for mesothelioma.
Research and Clinical Trials in New York
New York is home to groundbreaking mesothelioma research. A number of hospitals and cancer centers across the state are participating in unique and innovative mesothelioma clinical trials. These include research on CAR T-cell therapy.
Mesothelioma Clinical Trials in New York
- Roswell Park Comprehensive Cancer Center is participating in a phase II clinical trial evaluating whether the addition of photodynamic therapy can improve overall survival in patients with epithelioid pleural mesothelioma.
- Five locations in New York are participating in a phase I and phase II clinical trial that is recruiting peritoneal and pleural mesothelioma patients to test the safety and efficacy of the immunotherapy drug Bavencio (avelumab) in combination with stereotactic body radiation therapy.
- Four locations throughout New York are participating in a phase I clinical trial testing the safety of CAR T-cell therapy for malignant pleural mesothelioma. The novel treatment involves reprogramming a patient’s T cells to attack the cancer.
Cancer Support Services in New York
- CancerCare
Headquartered in New York City, CancerCare offers a variety of free 12-week programs for patients actively undergoing cancer treatment. The focus is typically on older adults. The organization provides information about treatment, coping with anxiety and community resources. An oncology social worker leads the group sessions and offers emotional and practical support.
- Cancer Support Team
Based in Westchester, Cancer Support Team provides at-home nursing care, counseling, case management and financial assistance, all free of charge. Volunteers provide transportation services and other support for cancer patients without regard to insurance coverage. Through donations, Cancer Support Team is also able to cover daily living costs for some patients.
- Memorial Sloan Kettering Cancer Center
One of the nation’s leading cancer treatment centers, Memorial Sloan Kettering runs multiple support groups and programs for patients with cancer and their families. Social workers, psychiatrists, psychologists and volunteers all work to deliver high-quality expertise and education for cancer patients. For those unable to visit the New York City location, Memorial Sloan Kettering also offers online virtual programs and community forums.
Mesothelioma Survivors from New York
Darlene Micciche
Peritoneal Mesothelioma Survivor
When Darlene Micciche was first told she had cancer, it wasn’t peritoneal mesothelioma. Her first diagnosis of stage 4 pancreatic cancer had a worse survival rate, so she was relieved when a second opinion revealed her true diagnosis of peritoneal mesothelioma. Kane performed her cytoreductive surgery with heated chemotherapy at Roswell Park Comprehensive Cancer Center. “We looked him up before we went because my oncologist [in Rochester] said you have to be comfortable with your surgeon,” said Micciche. “We ended up loving him from the start.”
Peter L.
Pleural Mesothelioma Survivor
Peter L. was 73 years old when he was diagnosed with pleural mesothelioma in 2013. Doctors told him he qualified for surgery and he decided to undergo a pleurectomy and decortication surgery in New York. About a year after the successful surgery, he joined an immunotherapy clinical trial. Two years later, the trial ended and Peter was told he had been receiving a placebo instead of the active immunotherapy drug. Despite receiving a placebo, he had no new cancer growth. “Most clinical trials fail. I know that, but you’re always looking to be that one in a million. I don’t think anyone should give up hope of finding it,” Peter said. “If the trial doesn’t help you, at least it will help someone who comes after you.”
